A Subclone of HuH-7 with Enhanced Intracellular Hepatitis C Virus Production and Evasion of Virus Related-Cell Cycle Arrest

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Murayama, Asako ^a   Sugiyama, Nao ^a   Yoshimura, Seiko ^b   Ishihara Sugano, Mitsuko ^b   Masaki, Takahiro ^a   Kim, Sulyi ^a   Wakita, Takaji ^a   Mishiro, Shunji ^c   Kato, Takanobu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b TOSHIBA CORPORATION   (Japan)

^c Tokyo Shina gawa Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ARTICLE; CELL CLONE; CELL CYCLE ARREST; CELL ISOLATION; CELL LINE; CELL POPULATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; VIROGENESIS; VIRUS PARTICLE; VIRUS REPLICATION;

CELL CYCLE CHECKPOINTS; CELL LINE; GENE EXPRESSION REGULATION; GENOTYPE; HEPACIVIRUS; HUMANS; VIRAL LOAD; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84871434654     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052697     Document Type: Article

References (35)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, et al. (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362.
2. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, et al. (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12: 671-675.
3. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH, (2000) Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med. 132: 296-305.
4. Feld JJ, Liang TJ, (2006) Hepatitis C - identifying patients with progressive liver injury. Hepatology 43: S194-206.
5. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
6. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102: 9294-9299.
7. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309: 623-626.
8. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J, (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42: 3858-3863.
9. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, et al. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113.
10. Sainz B Jr, Barretto N, Uprichard SL, (2009) Hepatitis C virus infection in phenotypically distinct Huh7 cell lines. PLoS One 4: e6561.
11. Akazawa D, Date T, Morikawa K, Murayama A, Miyamoto M, et al. (2007) CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol 81: 5036-5045.
12. Kato T, Date T, Miyamoto M, Sugiyama M, Tanaka Y, et al. (2005) Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system. J Clin Microbiol 43: 5679-5684.
13. Shimakami T, Welsch C, Yamane D, McGivern DR, Yi M, et al. (2011) Protease inhibitor-resistant hepatitis C virus mutants with reduced fitness from impaired production of infectious virus. Gastroenterology 140: 667-675.
14. Kato T, Date T, Murayama A, Morikawa K, Akazawa D, et al. (2006) Cell culture and infection system for hepatitis C virus. Nat Protoc 1: 2334-2339.
15. Murayama A, Weng L, Date T, Akazawa D, Tian X, et al. (2010) RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells. PLoS Pathog 6: e1000885.
16. Murayama A, Kato T, Akazawa D, Sugiyama N, Date T, et al. (2011) Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1. J Virol 86: 2143-2152.
17. Saeed M, Shiina M, Date T, Akazawa D, Watanabe N, et al. (2011) In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis. Hepatology 54: 425-433.
18. Gu B, Gates AT, Isken O, Behrens SE, Sarisky RT, (2003) Replication studies using genotype 1a subgenomic hepatitis C virus replicons. J Virol 77: 5352-5359.
19. Takeda M, Ikeda M, Ariumi Y, Wakita T, Kato N (2012) Development of Hepatitis C Virus Production Reporter Assay Systems Using Two Different Hepatoma Cell Lines. J Gen Virol.
20. Blight KJ, McKeating JA, Rice CM, (2002) Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76: 13001-13014.
21. Friebe P, Boudet J, Simorre JP, Bartenschlager R, (2005) Kissing-loop interaction in the 3′ end of the hepatitis C virus genome essential for RNA replication. J Virol 79: 380-392.
22. Ikeda M, Abe K, Dansako H, Nakamura T, Naka K, et al. (2005) Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system. Biochem Biophys Res Commun 329: 1350-1359.
23. Robinson M, Yang H, Sun SC, Peng B, Tian Y, et al. (2010) Novel hepatitis C virus reporter replicon cell lines enable efficient antiviral screening against genotype 1a. Antimicrob Agents Chemother 54: 3099-3106.
24. Sumpter R Jr, Loo YM, Foy E, Li K, Yoneyama M, et al. (2005) Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79: 2689-2699.
25. Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T, (2007) The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol 81: 588-598.
26. Kannan RP, Hensley LL, Evers LE, Lemon SM, McGivern DR, (2011) Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis. J Virol 85: 7989-8001.
27. Walters KA, Syder AJ, Lederer SL, Diamond DL, Paeper B, et al. (2009) Genomic analysis reveals a potential role for cell cycle perturbation in HCV-mediated apoptosis of cultured hepatocytes. PLoS Pathog 5: e1000269.
28. Yao ZQ, Eisen-Vandervelde A, Ray S, Hahn YS, (2003) HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1. Virology 314: 271-282.
29. Alisi A, Mele R, Spaziani A, Tavolaro S, Palescandolo E, et al. (2005) Thr 446 phosphorylation of PKR by HCV core protein deregulates G2/M phase in HCC cells. J Cell Physiol 205: 25-31.
30. Spaziani A, Alisi A, Sanna D, Balsano C, (2006) Role of p38 MAPK and RNA-dependent protein kinase (PKR) in hepatitis C virus core-dependent nuclear delocalization of cyclin B1. J Biol Chem 281: 10983-10989.
31. Yang XJ, Liu J, Ye L, Liao QJ, Wu JG, et al. (2006) HCV NS2 protein inhibits cell proliferation and induces cell cycle arrest in the S-phase in mammalian cells through down-regulation of cyclin A expression. Virus Res 121: 134-143.
32. Munakata T, Nakamura M, Liang Y, Li K, Lemon SM, (2005) Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase. Proc Natl Acad Sci U S A 102: 18159-18164.
33. Naka K, Dansako H, Kobayashi N, Ikeda M, Kato N, (2006) Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes. Virology 346: 348-362.
34. Wang Y, Xu Y, Tong W, Pan T, Li J, et al. (2011) Hepatitis C virus NS5B protein delays s phase progression in human hepatocyte-derived cells by relocalizing cyclin-dependent kinase 2-interacting protein (CINP). J Biol Chem 286: 26603-26615.
35. Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM, (2006) Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A 103: 2310-2315.